Key statistics
On Tuesday, Shield Therapeutics PLC (STX:LSE) closed at 10.75, -14.00% below its 52-week high of 12.50, set on Jan 16, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 10.50 |
|---|---|
| High | 10.75 |
| Low | 10.50 |
| Bid | -- |
| Offer | -- |
| Previous close | 11.00 |
| Average volume | 2.05m |
|---|---|
| Shares outstanding | 1.07bn |
| Free float | 304.54m |
| P/E (TTM) | -- |
| Market cap | 101.90m GBP |
| EPS (TTM) | -0.0177 GBP |
Data delayed at least 20 minutes, as of Feb 10 2026 17:08 GMT.
More ▼
Announcements
- FDA Grants additional Exclusivity for ACCRUFeR
- Total Voting Rights
- Approval for ACCRUFeR in China expected in Q1 2026
- Q4 2025 Trading Update
- Block listing 6 Monthly Return
- Total Voting Rights
- FDA approves extension for ACCRUFeR®
- Block Listing Application
- Shield Wins Gold at Titan Branding Awards
- Amends Senior Secured Debt Financing
More ▼
